Publication:
Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)

Simple item page
dc.contributor.authorGayoso, Jorge
dc.contributor.authorBalsalobre, Pascual
dc.contributor.authorKwon, Mi
dc.contributor.authorSampol Mayol, Antonia
dc.contributor.authorMontesinos, Pau
dc.contributor.authorSerrano, David
dc.contributor.authorHerrera, Pilar
dc.contributor.authorJesus Pascual, Maria
dc.contributor.authorBermudez, Arancha
dc.contributor.authorCastilla-Llorente, Cristina
dc.contributor.authorBento, Leyre
dc.contributor.authorChamp, Diana
dc.contributor.authorPerez-Corral, Ana
dc.contributor.authorBuces, Elena
dc.contributor.authorLuis Diez-Martin, Jose
dc.date.accessioned2024-07-04T12:54:54Z
dc.date.available2024-07-04T12:54:54Z
dc.date.issued2015-02
dc.descriptionBMT Tandem Meetings. San Diego, CA. FEB 11-15, 2015.
dc.format.number2 (S1)es_ES
dc.format.pageS186es_ES
dc.format.volume21es_ES
dc.identifier.citationGayoso J, Balsalobre P, Kwon M, Sampol A, Montesinos P, Serrano D, et al. Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS) [meeting abstract]. Biol Blood Marrow Transplant. 2015 Feb;21(Suppl 2):S186.en
dc.identifier.doi10.1016/j.bbmt.2014.11.283
dc.identifier.e-issn1523-6536es_ES
dc.identifier.issn1083-8791
dc.identifier.journalBiology of Blood and Marrow Transplantationes_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/17323
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20100
dc.identifier.wos348633000245
dc.language.isoengen
dc.publisherElsevier
dc.relation.publisherversionhttps://dx.doi.org/10.1016/j.bbmt.2014.11.283en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleMyeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)en
dc.typeconference presentationen
dspace.entity.typePublication
relation.isPublisherOfPublication7d471502-7bd5-4f7a-90a4-8274382509ef
relation.isPublisherOfPublication.latestForDiscovery7d471502-7bd5-4f7a-90a4-8274382509ef

Files

Collections

IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)